Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.
This bill requires New Jersey health insurance plans (carriers) to cover at least one abuse-deterrent opioid pain medication per active ingredient on their prescription formulary. It mandates that cost-sharing (like copays) for these abuse-deterrent drugs cannot exceed the lowest cost-sharing for similar non-abuse-deterrent opioids. The bill also prohibits requiring patients to try non-abuse-deterrent opioids first before accessing abuse-deterrent options. This applies to all health benefits plans delivered, issued, or renewed in New Jersey after the 90-day effective date following enactment.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2024
Committee Review
Floor Vote
Governor
Introduced Apr 15, 2024
Last action Apr 15, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Apr 15, 2024
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Brian Stack
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3128
Scope: NJ
Hi! I can help you understand S 3128. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline